HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib.

AbstractCONTEXT:
Pseudohypoparathyroidism (PHP) types Ia and Ib, are caused by mutations in GNAS exons 1-13 and GNAS methylation defects, respectively. PHP-Ia patients show Albright hereditary osteodystrophy (AHO) and resistance toward PTH and additional hormones, whereas PHP-Ib patients do not have AHO and hormone resistance is limited to PTH and, as reported in one paper, TSH. No study addressed the question of GH deficiency in PHP-Ib patients.
OBJECTIVES:
The objective of the study was to screen patients with clinically diagnosed PHP-Ib for genetic defects and investigate the presence of resistance to TSH and GHRH.
PATIENTS/METHODS:
We investigated GNAS differential methylation and STX16 microdeletions in genomic DNA from 10 patients with clinical diagnosis of sporadic PHP-Ib, i.e. PTH resistance without AHO. Resistance to GHRH was assessed by GH response to GHRH plus arginine. Thyroid function and ultrasonography were also evaluated.
RESULTS:
Molecular analysis showed GNAS cluster imprinting defects in all PHP-Ib patients and the first de novo STX16 deletion in one apparently sporadic patient. Subclinical or clinical hypothyroidism due to resistance to TSH was present in nine of 10 patients, whereas a preserved GH response to a GHRH plus arginine test was present in all patients, with one exception.
CONCLUSIONS:
We report the first molecular analysis of Italian patients with PHP-Ib. Clinical investigation shows that, like PHP-Ia patients, PHP-Ib patients are resistant to TSH, whereas they maintain a normal responsiveness to GHRH, at variance with PHP-Ia patients. These data provide new information on this rare disease and emphasize the clinical heterogeneity of genetic defects within GNAS.
AuthorsGiovanna Mantovani, Sara Bondioni, Agnès Linglart, Mohamad Maghnie, Mariangela Cisternino, Sabrina Corbetta, Andrea G Lania, Paolo Beck-Peccoz, Anna Spada
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 92 Issue 9 Pg. 3738-42 (Sep 2007) ISSN: 0021-972X [Print] United States
PMID17595244 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chromogranins
  • Human Growth Hormone
  • Insulin-Like Growth Factor I
  • Thyrotropin
  • Growth Hormone-Releasing Hormone
  • Arginine
  • GNAS protein, human
  • GTP-Binding Protein alpha Subunits, Gs
Topics
  • Adolescent
  • Adult
  • Arginine (administration & dosage)
  • Chromogranins
  • DNA Mutational Analysis
  • Drug Resistance (genetics)
  • Female
  • GTP-Binding Protein alpha Subunits, Gs (genetics)
  • Genetic Testing
  • Growth Hormone-Releasing Hormone (administration & dosage, pharmacology)
  • Human Growth Hormone (metabolism)
  • Humans
  • Insulin-Like Growth Factor I (analysis)
  • Male
  • Middle Aged
  • Pseudohypoparathyroidism (genetics)
  • Thyrotropin (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: